Christoph Correll to Risk Factors
This is a "connection" page, showing publications Christoph Correll has written about Risk Factors.
Connection Strength
0.089
-
Tardive Dyskinesia: Recognition, Patient Assessment, and Differential Diagnosis. J Clin Psychiatry. 2018 Mar/Apr; 79(2).
Score: 0.023
-
Clinical risk factors for the development of tardive dyskinesia. J Neurol Sci. 2018 06 15; 389:21-27.
Score: 0.023
-
Neuropsychological Test Performance to Enhance Identification of Subjects at Clinical High Risk for Psychosis and to Be Most Promising for Predictive Algorithms for Conversion to Psychosis: A Meta-Analysis. J Clin Psychiatry. 2017 01; 78(1):e28-e40.
Score: 0.021
-
Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis. Diabetes Obes Metab. 2019 02; 21(2):293-302.
Score: 0.006
-
The pharmacological management of metabolic syndrome. Expert Rev Clin Pharmacol. 2018 Apr; 11(4):397-410.
Score: 0.006
-
Pretreatment Cardiometabolic Status in Youth With Early-Onset Psychosis: Baseline Results From the TEA Trial. J Clin Psychiatry. 2017 Sep/Oct; 78(8):e1035-e1046.
Score: 0.005
-
Differential Risk of Increasing Psychotropic Polypharmacy Use in Children Diagnosed With ADHD as Preschoolers. J Clin Psychiatry. 2017 Jul; 78(7):e744-e781.
Score: 0.005